Search Results 6541-6550 of 25140 for oral

1. A Study to Evaluate Gleolan to Enhance Tumor Visualization in Patients with Newly-diagnosed or Recurrent Meningioma - Mayo Clinic

   About this study. The purpose of this study is to investigate the safety, diagnostic performance, and clinical usefulness of the imaging agent Gleolan™ ...

2. A Study to Test Sacituzumab Govitecan Therapy in Patients with HER2-Negative Breast Cancer and Brain Metastases - Mayo Clinic

   Participants who are able to switch to low molecular weight heparin (LMWH) or direct oral anticoagulants (DOACs) prior to date of registration (and plan to ...

3. Ulixertinib in People With Histiocytic Neoplasms - Mayo Clinic

   Inability to swallow oral medications; Prior stomach or duodenal resection that, in the opinion of the site PI, would affect the breakdown and absorption of ...

4. Mayo Clinic Minute Inside Your Voice AUDIO Ahh… A lot is happening in Kathy’s body to create the sounds she’s making in th

   That sound is shaped into words by muscles con- trolling the soft palate, tongue, oral cavity and lips. Some of the most common disorders that we see in our ...

5. Shelley S. Noland, M.D. - Doctors and Medical Staff - Mayo Clinic

   Oral Presentation selected as a Highlight of the Meeting (Hiredesai A, presenter) Annual Meeting Highlights Symposium, American Academy of Orthopaedic Surgeons.

6. Surgery - Doctors - Mayo Clinic

   Olson, M.D., M.S.. Rochester, MN. Areas of focus: Facial fracture repair, Rhinoplasty, Oral surgery, Face lift, Glossectomy, Nasal valve repair, Tonsillectomy ...

7. Osseointegration: Making prosthetics possible for high-leg amputations - Mayo Clinic

   Infections are usually mild and require oral antibiotics for 1 to 2 weeks. Osseointegration includes built-in safety features. If patients fall post ...

8. Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine - Mayo Clinic

   Previous participation in a clinical study of IV or oral rigosertib. Anemia due to factors other than MDS (including hemolysis or gastrointestinal [GI] ...

9. A Study to Evaluate the Effectiveness and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma - Mayo Clinic

   Inability of the participant to swallow and retain oral medication; Clinically significant or uncontrolled cardiac disease, including unstable angina, acute ...

10. Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma - Mayo Clinic

    Chronic corticosteroid use (systemic or oral) within six months prior to administration (Day 0). Known sensitivity or allergy to VEGF inhibitors or other ...